Clinical Trials Browser

Phase 1 × Solid Neoplasm × Erlotinib Hydrochloride × Clear all

NCT00085553 2018-05-18

Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Solid Neoplasm